Wellcome Centre for Mitochondrial Research, Newcastle University, Newcastle upon Tyne, UK.
Institute for Cell and Molecular Biosciences, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.
EMBO Mol Med. 2018 Nov;10(11). doi: 10.15252/emmm.201809060.
OXA1, the mitochondrial member of the YidC/Alb3/Oxa1 membrane protein insertase family, is required for the assembly of oxidative phosphorylation complexes IV and V in yeast. However, depletion of human OXA1 (OXA1L) was previously reported to impair assembly of complexes I and V only. We report a patient presenting with severe encephalopathy, hypotonia and developmental delay who died at 5 years showing complex IV deficiency in skeletal muscle. Whole exome sequencing identified biallelic variants (c.500_507dup, p.(Ser170Glnfs*18) and c.620G>T, p.(Cys207Phe)) that segregated with disease. Patient muscle and fibroblasts showed decreased OXA1L and subunits of complexes IV and V. Crucially, expression of wild-type human in patient fibroblasts rescued the complex IV and V defects. Targeted depletion of OXA1L in human cells or caused defects in the assembly of complexes I, IV and V, consistent with patient data. Immunoprecipitation of OXA1L revealed the enrichment of mtDNA-encoded subunits of complexes I, IV and V. Our data verify the pathogenicity of these variants and demonstrate that OXA1L is required for the assembly of multiple respiratory chain complexes.
OXA1 是 YidC/Alb3/Oxa1 膜蛋白插入酶家族的线粒体成员,是酵母氧化磷酸化复合物 IV 和 V 组装所必需的。然而,先前的研究表明,人源 OXA1(OXA1L)的耗竭仅会损害复合物 I 和 V 的组装。我们报告了一名患者,表现为严重的脑病、肌张力低下和发育迟缓,5 岁时死亡,骨骼肌中显示复合物 IV 缺乏。全外显子组测序鉴定出杂合性变异(c.500_507dup,p.(Ser170Glnfs*18)和 c.620G>T,p.(Cys207Phe)),与疾病共分离。患者肌肉和成纤维细胞中 OXA1L 和复合物 IV 和 V 的亚基减少。至关重要的是,在患者成纤维细胞中表达野生型人类 OXA1 可挽救复合物 IV 和 V 的缺陷。在人类细胞中靶向敲低 OXA1L 或 会导致复合物 I、IV 和 V 的组装缺陷,与患者数据一致。OXA1L 的免疫沉淀显示 mtDNA 编码的复合物 I、IV 和 V 的亚基富集。我们的数据验证了这些 变异的致病性,并表明 OXA1L 是组装多个呼吸链复合物所必需的。